Government Medical College, Nagpur Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2015
NCT01912677
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

labetalol (trandate) (1 trial)

methyldopa (aldomet) (1 trial)

nifedipine (procardia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertension (Phase 4)

Hypertension, Pregnancy-Induced (Phase 4)

Pre-Eclampsia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3